SI1231920T1 - Uporaba epinastina za zdravljenje alergijskega renitisa/konjuktivitisa - Google Patents

Uporaba epinastina za zdravljenje alergijskega renitisa/konjuktivitisa

Info

Publication number
SI1231920T1
SI1231920T1 SI200030938T SI200030938T SI1231920T1 SI 1231920 T1 SI1231920 T1 SI 1231920T1 SI 200030938 T SI200030938 T SI 200030938T SI 200030938 T SI200030938 T SI 200030938T SI 1231920 T1 SI1231920 T1 SI 1231920T1
Authority
SI
Slovenia
Prior art keywords
epinastin
conjunctivitis
treatment
allergic rhinitis
rhinitis
Prior art date
Application number
SI200030938T
Other languages
English (en)
Inventor
Volker Trach
Gerold Duschler
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7928843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1231920(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of SI1231920T1 publication Critical patent/SI1231920T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F01—MACHINES OR ENGINES IN GENERAL; ENGINE PLANTS IN GENERAL; STEAM ENGINES
    • F01L—CYCLICALLY OPERATING VALVES FOR MACHINES OR ENGINES
    • F01L9/00—Valve-gear or valve arrangements actuated non-mechanically
    • F01L9/20—Valve-gear or valve arrangements actuated non-mechanically by electric means
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00—Fluid handling
    • Y10T137/0318—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)
SI200030938T 1999-11-12 2000-10-14 Uporaba epinastina za zdravljenje alergijskega renitisa/konjuktivitisa SI1231920T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19954516A DE19954516A1 (de) 1999-11-12 1999-11-12 Epinastin-haltige Lösungen
EP00972763A EP1231920B1 (de) 1999-11-12 2000-10-14 Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis
PCT/EP2000/010122 WO2001035962A1 (de) 1999-11-12 2000-10-14 Epinastin-haltige lösungen

Publications (1)

Publication Number Publication Date
SI1231920T1 true SI1231920T1 (sl) 2007-06-30

Family

ID=7928843

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030938T SI1231920T1 (sl) 1999-11-12 2000-10-14 Uporaba epinastina za zdravljenje alergijskega renitisa/konjuktivitisa

Country Status (40)

Country Link
US (6) US20030050303A1 (sl)
EP (1) EP1231920B1 (sl)
JP (1) JP2003514021A (sl)
KR (1) KR100758842B1 (sl)
CN (1) CN1292752C (sl)
AR (1) AR026424A1 (sl)
AT (1) ATE353218T1 (sl)
AU (2) AU784017B2 (sl)
BG (1) BG65775B1 (sl)
BR (1) BR0015477A (sl)
CA (1) CA2391076C (sl)
CO (1) CO5251448A1 (sl)
CY (1) CY1106375T1 (sl)
CZ (1) CZ302483B6 (sl)
DE (2) DE19954516A1 (sl)
DK (1) DK1231920T3 (sl)
EA (1) EA006937B1 (sl)
EE (1) EE05395B1 (sl)
ES (1) ES2281359T3 (sl)
HK (1) HK1052303B (sl)
HR (1) HRP20020404B1 (sl)
HU (1) HU229502B1 (sl)
IL (2) IL149501A0 (sl)
ME (1) MEP36708A (sl)
MX (1) MXPA02004556A (sl)
MY (1) MY130441A (sl)
NO (1) NO329417B1 (sl)
NZ (1) NZ519425A (sl)
PE (1) PE20010826A1 (sl)
PL (1) PL198879B1 (sl)
PT (1) PT1231920E (sl)
RS (1) RS50173B (sl)
SA (1) SA01210658B1 (sl)
SI (1) SI1231920T1 (sl)
SK (1) SK287343B6 (sl)
TR (1) TR200201270T2 (sl)
TW (1) TWI225401B (sl)
UA (1) UA74563C2 (sl)
WO (1) WO2001035962A1 (sl)
ZA (1) ZA200203683B (sl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
WO2004014353A1 (en) * 2002-08-02 2004-02-19 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
US20040247686A1 (en) * 2003-04-04 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
EP1468696A1 (en) * 2003-04-17 2004-10-20 Boehringer Ingelheim International GmbH Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
KR20080034916A (ko) * 2005-07-08 2008-04-22 센주 세이야꾸 가부시키가이샤 에피나스틴을 포함하는 경피 흡수 안과 제제
US7378082B1 (en) 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
WO2008098122A2 (en) * 2007-02-08 2008-08-14 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US20080194544A1 (en) * 2007-02-08 2008-08-14 Ramesh Krishnamoorthy Aqueous formulations of epinastine for treating allergic rhinitis
US20120203161A1 (en) * 2009-08-12 2012-08-09 Seros Medical, Llc Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method of use
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
EP2630952A1 (en) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
JP6373867B2 (ja) * 2012-12-19 2018-08-15 サルコード・バイオサイエンス・インコーポレイテッド Ｌｆａ−１阻害剤製剤
CN104491876A (zh) * 2014-12-23 2015-04-08 中国药科大学 含玻璃酸钠的依匹斯汀滴眼液及其制备方法
ITUB20153950A1 (it) * 2015-09-28 2017-03-28 Tred Srl Dispositivo nasale in grado di attivare il riflesso rino-palatale per l'igienizzazione rinofaringea
JP6134853B1 (ja) * 2016-10-28 2017-05-24 参天製薬株式会社 エピナスチン含有点眼液
JP6635974B2 (ja) * 2017-04-24 2020-01-29 参天製薬株式会社 エピナスチン含有点眼液
TW201841620A (zh) * 2017-05-01 2018-12-01 日商參天製藥股份有限公司 點眼劑
JP2019108320A (ja) * 2018-10-31 2019-07-04 参天製薬株式会社 ソフトコンタクトレンズの変質を抑制する眼科用組成物
JP6736752B2 (ja) * 2019-12-17 2020-08-05 参天製薬株式会社 エピナスチン含有点眼液
JP6963651B2 (ja) * 2020-04-16 2021-11-10 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP7118579B1 (ja) 2020-04-16 2022-08-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP2020169213A (ja) * 2020-07-15 2020-10-15 参天製薬株式会社 エピナスチン含有点眼液
CN115448927A (zh) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 一种氢溴酸依匹斯汀晶型ii及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US151541A (en) * 1874-06-02 Improvement in hay-loaders
US104017A (en) * 1870-06-07 Improvement in embroidering attachment for sewing-machines
US203021A (en) * 1878-04-30 Improvement in side-bar wagons
US8632A (en) * 1852-01-06 George hess
US228359A (en) * 1880-06-01 jones
US215396A (en) * 1879-05-13 Improvement in loom-temples
US181478A (en) * 1876-08-22 Improvement in water-wheels
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
US5668133A (en) * 1992-12-09 1997-09-16 Alcon Laboratories, Inc. Ophthalmic compositions comprising emedastine and methods for their use
EP0835098B1 (de) * 1995-06-27 2002-09-04 Boehringer Ingelheim Pharma KG Neue stabile arzneimittelzubereitung zur erzeugung treibgasfreier aerosole
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
CA2264172A1 (en) * 1996-08-30 1998-03-05 Kyoto Pharmaceutical Industries, Ltd. Remedies for allergic dermatitis
US20030215396A1 (en) * 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
EP1242090A4 (en) * 1999-11-18 2004-02-11 Alcon Inc USE OF AN H1 ANTAGONIST AND A SAFE STEROID IN THE TREATMENT OF EYE CONDITIONS
DE19958460A1 (de) * 1999-12-03 2001-06-07 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
FR2803520B1 (fr) * 2000-01-12 2002-09-20 Ceva Sante Animale Procede pour augmenter la production d'oeufs et consolider la coquille des oeufs chez les volailles
US20020094345A1 (en) * 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
DE10119718A1 (de) * 2001-04-21 2002-10-31 Boehringer Ingelheim Pharma Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
WO2002098112A2 (en) * 2001-05-29 2002-12-05 Transchip, Inc. Patent application cmos imager for cellular applications and methods of using such
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
EP1350512A1 (en) * 2002-04-03 2003-10-08 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
US6863848B2 (en) * 2002-08-30 2005-03-08 Signet Armorlite, Inc. Methods for preparing composite photochromic ophthalmic lenses
JP2007145316A (ja) * 2005-10-27 2007-06-14 Nissan Motor Co Ltd 遮光装置とサンバイザーとサンルーフユニット

Also Published As

Publication number Publication date
MY130441A (en) 2007-06-29
RS50173B (sr) 2009-05-06
EA006937B1 (ru) 2006-06-30
CY1106375T1 (el) 2011-10-12
CA2391076C (en) 2008-06-17
AU784017B2 (en) 2006-01-12
US20070197503A1 (en) 2007-08-23
KR20020050273A (ko) 2002-06-26
ZA200203683B (en) 2003-09-03
YU33602A (sh) 2005-03-15
ATE353218T1 (de) 2007-02-15
EA200200492A1 (ru) 2002-10-31
NO329417B1 (no) 2010-10-18
CZ20021956A3 (cs) 2002-08-14
US20050288274A1 (en) 2005-12-29
NO20022201D0 (no) 2002-05-08
TWI225401B (en) 2004-12-21
US20030050303A1 (en) 2003-03-13
DK1231920T3 (da) 2007-04-10
UA74563C2 (uk) 2006-01-16
DE50014041D1 (de) 2007-03-22
IL149501A0 (en) 2002-11-10
SK287343B6 (sk) 2010-07-07
TR200201270T2 (tr) 2002-12-23
JP2003514021A (ja) 2003-04-15
HRP20020404B1 (en) 2007-08-31
MXPA02004556A (es) 2004-09-10
US20090239842A1 (en) 2009-09-24
CN1390129A (zh) 2003-01-08
MEP36708A (en) 2011-02-10
AU1138101A (en) 2001-05-30
SK8302002A3 (en) 2002-09-10
CN1292752C (zh) 2007-01-03
IL149501A (en) 2012-04-30
PL198879B1 (pl) 2008-07-31
ES2281359T3 (es) 2007-10-01
BG65775B1 (bg) 2009-11-30
NZ519425A (en) 2004-04-30
US7429602B2 (en) 2008-09-30
CA2391076A1 (en) 2001-05-25
EP1231920B1 (de) 2007-02-07
US20080009476A1 (en) 2008-01-10
DE19954516A1 (de) 2001-05-17
HK1052303B (zh) 2007-04-13
HUP0203773A3 (en) 2005-01-28
HK1052303A1 (en) 2003-09-11
WO2001035962A1 (de) 2001-05-25
BG106681A (en) 2002-12-29
EE05395B1 (et) 2011-04-15
EP1231920A1 (de) 2002-08-21
KR100758842B1 (ko) 2007-09-19
NO20022201L (no) 2002-05-08
HU229502B1 (en) 2014-01-28
AR026424A1 (es) 2003-02-12
BR0015477A (pt) 2002-06-25
US20070185082A1 (en) 2007-08-09
PE20010826A1 (es) 2001-08-20
PL364028A1 (en) 2004-11-29
EE200200246A (et) 2003-06-16
PT1231920E (pt) 2007-03-30
CO5251448A1 (es) 2003-02-28
HRP20020404A2 (en) 2004-08-31
HUP0203773A2 (hu) 2003-03-28
SA01210658B1 (ar) 2006-11-05
AU2006201541A1 (en) 2006-05-11
CZ302483B6 (cs) 2011-06-08

Similar Documents

Publication Publication Date Title
SI1231920T1 (sl) Uporaba epinastina za zdravljenje alergijskega renitisa/konjuktivitisa
HK1047284A1 (en) 2-amino-benzoxazinone derivatives for the treatment of obesity
HUP0302719A3 (en) Substituted amine derivatives and their use for the treatment of angiogenesis
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO20013381D0 (no) 2-oksybenzoksazinonderivater for behandling av fedme
NO20022087L (no) Fremgangsmåte for behandling av diabetes
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL145301A0 (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
AP2005003336A0 (en) Combination for the treatment of ADHD
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
EP1461030A4 (en) AMINOALKYL-BENZOFURAN-5-OL COMPOUNDS FOR THE TREATMENT OF GLAUCOMA
PL375564A1 (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
EP1455780A4 (en) NEW BENZODIFURANIMIDAZOLIN AND BENZOFURANIMIDAZOLIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF GLAUCOMA
IL150290A0 (en) The use of mirtazapine for the treatment of sleep disorders
HK1059782A1 (en) Indole derivatives useful for the treatment of cnsdisorders
CZ20011872A3 (cs) Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny
PT1698338E (pt) S-metil-di-hidro-ziprasidona para o tratamento de distúrbios psiquiátricos
HK1043938A1 (en) Composition for the treatment of psoriasis
PT1451177E (pt) Derivados substituídos de 2-pirrolidin-2-1l-1h-indole para o tratamento da enxaqueca.
IS6020A (is) S-nítrósóþíól til meðferðar við blóðrásartruflunum
AU8626398A (en) Inhibitors of the phosphodiesterase-4 for the treatment of allergic rhinitis
EP1423125A4 (en) OESTROGENES NOT INDUCING FEMINIZATION AS PROTECTIVE AGENTS ON RETINA IN THE TREATMENT OF GLAUCOMA
GB9926985D0 (en) Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and-cyanamides for the treatment of diseases
AU2002319989A1 (en) Heterocyclic amines for the treatment of conditions associated with gsk-3